EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 16, 2014 | $500,000 | Replaced |
| 3rd Quarter - Amendment | Nov 11, 2014 | $500,000 | Yes |
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Pharmacy issues related to Section 700 (Champus provisions) of the annual defense bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| NANCY GILBRIDE | — |
| GARY J KLINE | Office of Congressman Brian Bilbray |
| MARY M ROSADO | — |
| SERGIO SANTIVIAGO | — |
Taxation/Internal Revenue Code TAX
Regulatory implementation of various tax provisions in the health reform legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY J KLINE | Office of Congressman Brian Bilbray |
| MARY M ROSADO | — |
| SERGIO SANTIVIAGO | — |
Postal POS
Postal Reform proposals and their impact on 6 day mail delivery
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARY M ROSADO | — |
Labor Issues/Antitrust/Workplace LBR
Legislation to exempt certain pharmacies from the antitrust laws for purposes of negotiating with payers (HR 1188)
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY J KLINE | Office of Congressman Brian Bilbray |
| MARY M ROSADO | — |
| SERGIO SANTIVIAGO | — |
Medicare/Medicaid MMM
Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap. General reg/leg Part D issues such as direct negotiation (budget proposals). Statutory implementation of changes to the definition of AMP in Medicaid. Exclusion of specialty distributors' prompt pay discounts from the definition of Average Sales Price. Medicare audit and preferred network restrictions. S. 867, Medicare Prescription Drug Integrity andAnd Transparency Act of 2013 and other versions (HR 4437, S. 867, HR 4577. General issues and legislation (HR 3392) regarding combatting Rx abuse in Medicare and Medicaid (pharmacy lock-in, etc)
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY J KLINE | Office of Congressman Brian Bilbray |
| MARY M ROSADO | — |
| SERGIO SANTIVIAGO | — |
Pharmacy PHA
Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); specialty pharmacy tiering restrictions (HR 460); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act); S. 867 (and versions HR 4437, HR 4577), the Medicare Prescription Drug Program Integrity and Transparency Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NANCY GILBRIDE | — |
| GARY J KLINE | Office of Congressman Brian Bilbray |
| MARY M ROSADO | — |
| SERGIO SANTIVIAGO | — |
Health Issues HCR
Regulatory policies related to health reform legislation: structure, drug benefits, disclosure Regulatory implementation of HITECH/Accounting of Disclosures Issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). Restrictions on specialty tiering; HR 460
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY J KLINE | Office of Congressman Brian Bilbray |
| MARY M ROSADO | — |
| SERGIO SANTIVIAGO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.